By David Wetzel New York (Knewz) — In June the Food and Drug administration is scheduled to convene to discuss requests for vaccine approval for children under 6 years old. The FDA has meetings scheduled for June 7, June 8, 21 and 22, and June 28 to discuss a variety of COVID-19 topics, including possible approval of vaccines for children under 6 years old. On June 7, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is scheduled to discuss Emergency Use Authorization (EAU) for a vaccine produced by Novavax to prevent COVID-19 in people 18 years and older. On June …
